Navegação Ciências da Saúde por Assunto "Papillomavirus humano 16"
Resultados 1-4 de 4
-
Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04- adjuvanted vaccine against cervical infection and precancer in young women : final event-driven analysis of the randomized, double- blind PATRICIA trial
(2015) [Artigo de periódico]We report final event-driven analysis data on the immunogenicity and efficacy of the human papillomavirus 16 and 18 ((HPV- 16/18) AS04-adjuvanted vaccine in young women aged 15 to 25 years from the PApilloma TRIal against ... -
Post Hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA
(2015) [Artigo de periódico]The efficacy of the human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against cervical infections with HPV in the Papilloma Trial against Cancer in Young Adults (PATRICIA) was evaluated using a combination ... -
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies : analysis of the control arm of PATRICIA
(2014) [Artigo de periódico]Background. We examined risk of newly detected human papillomavirus (HPV) infection and cervical abnormalities in relation to HPV type 16/18 antibody levels at enrollment in PATRICIA (Papilloma Trial Against Cancer in Young ... -
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine : up to 8.4 years of follow-up
(2012) [Artigo de periódico]Prophylactic human papillomavirus (HPV) vaccines are now available and vaccination programs are being widely implemented, targeting adolescent girls prior to sexual debut. Since the risk of HPV exposure persists throughout ...